Condition (MeSH)
Sialadenitis
ClinicalTrials.gov lists 5 trials for Sialadenitis or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
3 of the 5 trials are tagged with Sialadenitis itself; the rest are tagged with a narrower condition beneath it.
When did Sialadenitis trials start? (5)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1/2
- Not applicable
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2020 | 1 |
| 2018 | 1 |
| 2016 | 1 |
| 2012 | 1 |
| 2004 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 5 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Sialadenitis trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1/2 | 1 |
| Not applicable | 3 |
| Observational | 1 |
How many Sialadenitis trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 3 |
| Unknown status | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which serious adverse events do Sialadenitis trials report? (6)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Amaurosis fugax | 1 | 1 |
| Klebsiella urinary tract infection | 1 | 1 |
| Legionella pneumophila pneumonia | 1 | 1 |
| Surgery for pseudotumor | 1 | 1 |
| cold agglutininmediated | 1 | 1 |
Showing 5 of 6 adverse events.
Which publications cover Sialadenitis? (10)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Sclerosing Sialadenitis Is Associated With Salivary Gland Hypofunction and a Unique Gene Expression Profile in Sjögren's Syndrome. | Frontiers in immunology | 2021 | Yes |
| Pathophysiology of IgG4-related disease: A T follicular helper cells disease? | Presse medicale (Paris, France : 1983) | 2020 | Yes |
| 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: A consensus and data-driven methodology involving three international patient cohorts. | Annals of the rheumatic diseases | 2017 | Yes |
| MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndrome. | Arthritis and rheumatism | 2011 | Yes |
| Pilocarpine for the treatment of salivary glands' impairment caused by radioiodine therapy for thyroid cancer. | Oral diseases | 2006 | Yes |
Showing 5 of 10 publications.
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, prevalence, and rare-disease identity.
Not computed for conditions with fewer than 10 trials: drugs tested.